Primary Immunosuppression With Tacrolimus in Renal Transplantation: A Single Center Experience

Authors
H.C. KimS.B. ParkS.Y. HanE.A. WhangD.S. JeonH.T. KimW.H. ChoC.H. Park
Department
Dept. of Internal Medicine (내과학); Dept. of Laboratory Medicine (진단검사의학); Dept. of Surgery (외과학); Dept. of Urology (비뇨의학); Kidney Institute (신장연구소)
Issue Date
2003
Citation
Transplantation Proceedings, Vol.35(1) : 217-218, 2003
ISSN
0041-1345
Abstract
Tacrolimus (FK-506) has shown potent immunosuppressive activity both in vitro and in vivo.¹,² Previous clinical trials in Japan, Europe, and the United States suggest that tacrolimus is an effective primary immunosuppressive agent in kidney transplantation3-5 The present retrospective, nonrandomized single-center study was performed to confirm the efficacy and safety of tacrolimus as a primary immunosuppressive agent in kidney transplantation.
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/34719
Appears in Collections:
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Laboratory Medicine (진단검사의학)
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Surgery (외과학)
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Urology (비뇨의학)
1. Journal Papers (연구논문) > 3. Research Institutues (연구소) > Kidney Institute (신장연구소)
Keimyung Author(s)
김현철; 박성배; 한승엽; 황은아; 전동석; 김형태; 조원현; 박철희
Full Text
https://www.sciencedirect.com/science/article/pii/S0041134502040174?via%3Dihub
File in this Item
 사서에게 요청하기
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE